Skip to content

Improving Walking Quality and Quantity in Osteoarthritis (IWALQQ-OA)

Improving Walking Quality and Quantity in Osteoarthritis (IWALQQ-OA): A Feasibility Study

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03064139
Acronym
IWALQQ-OA
Enrollment
47
Registered
2017-02-24
Start date
2019-03-07
Completion date
2021-03-18
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

physical activity, gait, biomechanics, mindfulness

Brief summary

This study evaluates the feasibility of a mindful walking intervention for management of knee osteoarthritis. Participants will be randomly assigned to receive one of two interventions i.e. mindful walking intervention or a self-care intervention.

Detailed description

People with knee osteoarthritis have low levels of physical activity, especially walking activity. They also walk with abnormal walking biomechanics that are associated with greater knee loading. Therefore, it is important to increase the levels of walking activity in people with knee osteoarthritis, but also change their walking patterns to reduce knee loading. This study will last 12 months and participants will be randomized into 2 groups. For the first 6-months, half of the participants will attend sessions at a community location that include training in mindful walking technique. The other half will meet for the same frequency and duration at a community location for education on osteoarthritis and its management (focusing on symptom management, importance of physical activity, weight management, etc.). Both groups will also receive a wrist-worn activity monitor and a smartphone application that they will use throughout the study. After 6-months all participants will be allowed to practice on their own. All participants will complete gait analysis, knee MRI, questionnaires, physical function assessment at baseline and at 6-months. All participants will also complete questionnaires at 3,9, and 12 months. Weekly physical activity and knee pain data will be collected using the mobile health technology for 12- months.

Interventions

BEHAVIORALMCG

Community-based in person group training n mindful walking over 11 sessions in 6-months+ Activity monitor with feedback on activity levels

BEHAVIORALSCG

Community-based in person group education in management of knee osteoarthritis (importance of physical activity, weight management, etc.) over 11 sessions in 6 months + Activity monitor with feedback on activity levels

Sponsors

Boston University Charles River Campus
Lead SponsorOTHER
Boston University
CollaboratorOTHER
University of Delaware
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* age 50-80 years * BMI ≤40 kg/m2 * Meet American College of Rheumatology clinical and/or clinical+radiographic criteria for knee osteoarthritis * Knee pain score ≥ 4 during last week * Predominantly medial knee pain * Predominantly medial knee radiographic osteoarthritis with or without radiographic patellofemoral osteoarthritis * Ability to ambulate for a minimum of 20 minutes, without any assistive device * Available for the study duration * Own a smartphone * Can speak and understand English

Exclusion criteria

* Contraindications to exercise * Using orthotics for knee pain such as knee braces, wedge insoles * Knee injection in previous 3-months * Currently receiving physical therapy for knee pain * Planning major treatment for knee pain (e.g., physical therapy, surgery) in next 6 months * Self-reported joint diseases like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, gout, etc. * Self-reported total joint replacement in any lower extremity joint * Self-reported neurological conditions like stroke, Parkinson's disease, etc. * Self-reported muscular disease like muscle dystrophy * Self-reported musculoskeletal or neurologic conditions that affect gait.

Design outcomes

Primary

MeasureTime frameDescription
Adherence (in %)6-monthsMeasured as % of in-person training sessions attended by participants
Retention (in %)6-monthsMeasured as the % of participants returning for the post-intervention assessment

Secondary

MeasureTime frameDescription
Medial knee contact force during walking (in Newton)Change from baseline to 6-monthsMedial knee contact force derived using an EMG-Driven musculoskeletal model
Average Daily Activity CountChange from baseline to 6-monthsMeasured using an activity monitor worn by the participants
Knee injury and Osteoarthritis Outcome Score (KOOS) Pain SubscaleChange from baseline to 6-monthsPatient-reported outcome

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDeepak Kumar, PT, PhD

Boston University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026